Format

Send to

Choose Destination
See comment in PubMed Commons below
Brain Res. 2007 May 25;1147:77-88. Epub 2007 Feb 22.

Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease.

Author information

  • 1Dept. Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA. deanna_marchionini@rush.edu

Abstract

The developmental biology of the dopamine (DA) system may hold important clues to its reconstruction. We hypothesized that factors highly expressed during nigrostriatal development and re-expressed after injury and disease may play a role in protection and reconstruction of the nigrostriatal system. Examination of gene expression in the developing striatum suggested an important role for the heparin binding growth factor family at time points relevant to establishment of dopaminergic innervation. Midkine, pleiotrophin (PTN), and their receptors syndecan-3 and receptor protein tyrosine phosphatase beta/zeta, were highly expressed in the striatum during development. Furthermore, PTN was up-regulated in the degenerating substantia nigra of Parkinson's patients. The addition of PTN to ventral mesencephalic cultures augmented DA neuron survival and neurite outgrowth. Thus, PTN was identified as a factor that plays a role in the nigrostriatal system during development and in response to disease, and may therefore be useful for neuroprotection or reconstruction of the DA system.

PMID:
17368428
DOI:
10.1016/j.brainres.2007.02.028
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center